SQZ Biotechnologies Company (SQZB)
OTCMKTS · Delayed Price · Currency is USD
0.0250
-0.0030 (-10.71%)
Dec 27, 2024, 4:00 PM EST

SQZB Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Period Ending
Sep '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Net Income
-71.64-79.46-68.74-50.52-32.2-20.23
Depreciation & Amortization
11.4511.6811.0310.944.361.07
Loss (Gain) From Sale of Assets
-0.120.030.01-0.05-
Loss (Gain) From Sale of Investments
----0.01-0.97-0.46
Stock-Based Compensation
4.68.48.513.62.110.59
Other Operating Activities
---0.11-0.98
Change in Accounts Receivable
-3-1.11-0.02-1.01-0.37
Change in Accounts Payable
-1.4-1.421.070.11.710.43
Change in Unearned Revenue
-12.7-20.99-23.874.75-4.936.95
Change in Other Net Operating Assets
-10.52-4.8-9.03-12.11-2.642.13
Operating Cash Flow
-74.33-83.55-82.14-43.15-33.4921.1
Capital Expenditures
-0.21-0.52-0.61-1.18-2.17-1.31
Sale of Property, Plant & Equipment
0.170.03----
Investment in Securities
---59-10.68-35.66
Investing Cash Flow
-0.04-0.49-0.6157.82-12.85-36.96
Issuance of Common Stock
0.334.2357.8175.930.090.09
Other Financing Activities
---1.9-1.76--
Financing Cash Flow
0.334.2355.91116.4226.0468.12
Net Cash Flow
-74.05-79.8-26.84131.09-20.352.26
Free Cash Flow
-74.55-84.07-82.75-44.33-35.6619.79
Free Cash Flow Margin
-615.02%-391.43%-305.37%-211.11%-177.33%156.22%
Free Cash Flow Per Share
-2.53-2.92-3.00-8.21-20.9213.13
Levered Free Cash Flow
-29.51-33.59-38.4-13.34-11.25-
Unlevered Free Cash Flow
-29.51-33.59-38.4-13.34-11.25-
Change in Net Working Capital
75.3814.34-5.21-5.87-
Source: S&P Capital IQ. Standard template. Financial Sources.